The Bayer team at the financial news conference in London on Tuesday. (Credit: Bayer)
Bayer says no breakup ‘for now,’ focuses instead on fixing ‘badly broken’ areas
Bayer isn’t ready to break up its pharma, consumer and crop science divisions just yet. Instead, CEO Bill Anderson wants to focus on tackling the …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
